Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the public-private push to accelerate cancer vaccine ...

His comments come after Merck officially opened its new 120,000-square-foot research facility in the Greater Philadelphia ...

A study by Australian researchers compared three mRNA-LNP vaccine platforms in human blood samples, generating findings that ...

MRNA, BNTX and NVAX shares rally after reports of a planned NIH-backed initiative to accelerate personalized cancer vaccines ...

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

Moderna has surged more than 650% this year on cancer vaccine excitement, but analyst targets sit far below the current share ...

Moderna was recently added to the Nasdaq-100 Index after positive Phase 3 data for its personalized cancer vaccine with Merck ...

Developing a vaccine: UNC’s Lineberger Cancer Center has received a $40 million grant to support vaccine development using AI ...

LONDON, Oct. 16 (Xinhua) -- British researchers are bringing artificial intelligence (AI), automated laboratories and supercomputing together to accelerate the development of personalized cancer ...

A recent report finds that pathogens contribute to a significant number of cancer cases.

- Moderna's stock fell nearly 10% as its cancer vaccine's valuation outpaces analyst targets by ~$35B. - The personalized ...